| The nature of myeloid-derived suppressor cells in the tumor microenvironment V Kumar, S Patel, E Tcyganov, DI Gabrilovich Trends in immunology 37 (3), 208-220, 2016 | 1887 | 2016 |
| Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors Cancer Cell 32 (5), 654-668, 2017 | 544 | 2017 |
| Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer JI Youn, V Kumar, M Collazo, Y Nefedova, T Condamine, P Cheng, ... Nature immunology 14 (3), 211-220, 2013 | 373 | 2013 |
| CD45 phosphatase inhibits STAT3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation V Kumar, P Cheng, T Condamine, S Mony, LR Languino, JC McCaffrey, ... Immunity 44 (2), 303-315, 2016 | 358 | 2016 |
| Hypoxia‐inducible factors in regulation of immune responses in tumour microenvironment V Kumar, DI Gabrilovich Immunology 143 (4), 512-519, 2014 | 340 | 2014 |
| ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis T Condamine, V Kumar, IR Ramachandran, JI Youn, E Celis, N Finnberg, ... The Journal of clinical investigation 124 (6), 2626-2639, 2014 | 331 | 2014 |
| Age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-cell populations CH Kugel III, SM Douglass, MR Webster, A Kaur, Q Liu, X Yin, SA Weiss, ... Clinical Cancer Research 24 (21), 5347-5356, 2018 | 304 | 2018 |
| Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells R Behera, V Kumar, K Lohite, S Karnik, GC Kundu Carcinogenesis 31 (2), 192-200, 2010 | 174 | 2010 |
| The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis G Chakraborty, S Jain, R Behera, M Ahmed, P Sharma, V Kumar, ... Current molecular medicine 6 (8), 819-830, 2006 | 164 | 2006 |
| The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia GC Issa, I Aldoss, J DiPersio, B Cuglievan, R Stone, M Arellano, ... Nature 615 (7954), 920-924, 2023 | 121 | 2023 |
| Distinct populations of immune-suppressive macrophages differentiate from monocytic myeloid-derived suppressor cells in cancer T Kwak, F Wang, H Deng, T Condamine, V Kumar, M Perego, ... Cell reports 33 (13), 2020 | 119 | 2020 |
| Effects of notch signaling on regulation of myeloid cell differentiation in cancer P Cheng, V Kumar, H Liu, JI Youn, M Fishman, S Sherman, D Gabrilovich Cancer research 74 (1), 141-152, 2014 | 104 | 2014 |
| p38 kinase is crucial for osteopontin-induced furin expression that supports cervical cancer progression V Kumar, R Behera, K Lohite, S Karnik, GC Kundu Cancer research 70 (24), 10381-10391, 2010 | 97 | 2010 |
| Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17–producing CD4+ T cells ML Ortiz, V Kumar, A Martner, S Mony, L Donthireddy, T Condamine, ... Journal of Experimental Medicine 212 (3), 351-367, 2015 | 90 | 2015 |
| Osteopontin: a potentially important therapeutic target in cancer M Ahmed, R Behera, G Chakraborty, S Jain, V Kumar, P Sharma, ... Expert opinion on therapeutic targets 15 (9), 1113-1126, 2011 | 86 | 2011 |
| Pena de la Vega L, Farell G, Lieske JC. Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers V Kumar Kidney Int 68 (4), 1784-1792, 2005 | 40 | 2005 |
| Myeloid-derived suppressor cells are a major source of Wnt5A in the melanoma microenvironment and depend on Wnt5A for full suppressive activity SM Douglass, ME Fane, E Sanseviero, BL Ecker, CH Kugel III, R Behera, ... Cancer research 81 (3), 658-670, 2021 | 19 | 2021 |
| Axatilimab for chronic graft-versus-host disease after failure of at least two prior systemic therapies: results of a phase I/II study CL Kitko, M Arora, Z DeFilipp, MA Zaid, A Di Stasi, V Radojcic, CB Betts, ... Journal of Clinical Oncology 41 (10), 1864-1875, 2023 | 15 | 2023 |
| AK., sdan Fausto, N. 2005 VA Kumar Hypertensive Vascular Disease. Dalam: Robin and Cotran Pathologic Basis of …, 2007 | 11 | 2007 |
| Robbin’s pathogenic basis of disease RS Cortan, V Kumar Philadelphia: WB Saunders 163, 164, 1998 | 9 | 1998 |
